CCDC44 Antibodies

Santa Cruz Biotechnology provides a broad selection of CCDC44 monoclonal antibodies for advanced research in cellular and molecular biology. CCDC44 Antibodies targeting CCDC44 are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CCDC44, or Coiled-Coil Domain Containing 44, plays a crucial role in cellular processes such as cell division and cytoskeletal organization. The involvement of CCDC44 in the regulation of cellular architecture makes it a significant focus for understanding various biological functions and disease mechanisms. Research on CCDC44 can provide insights into its potential implications in cancer and other pathologies. Scientists worldwide rely on CCDC44 monoclonal antibodies to advance their understanding of cellular processes and disease progression. The exceptional specificity of CCDC44 monoclonal antibodies enables precise detection and analysis of cellular components. CCDC44 monoclonal antibodies from Santa Cruz Biotechnology support researchers in their mission to uncover new therapeutic targets and advance scientific knowledge.